Skip to main content

Roche targets DNA sequencing technology in $350 million deal for Genia

Drug-development powerhouse Roche will buy DNA sequencing system developer Genia Technologies Inc. for as much as $350 million, according to terms of a deal disclosed Sunday...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.